Company Filing History:
Years Active: 2000
Title: Edward A Sugden: Innovator in Rapid Detection Methods
Introduction
Edward A Sugden is a notable inventor based in Nepean, Canada. He has made significant contributions to the field of biotechnology, particularly in the rapid detection of infectious diseases. His innovative approach has led to the development of a unique assay that enhances the detection of Mycobacterium bovis.
Latest Patents
Sugden holds a patent for a "Rapid detection method of Mycobacterium bovis by fluorescence." This patent describes an assay that detects antibodies to the MPB70 protein secreted by Mycobacterium bovis. The method utilizes a tracer consisting of the MPB70 protein conjugated to a fluorophore, such as fluorescein. When mixed with antibodies specific to the MPB70 protein found in the serum of infected animals, the bound tracer exhibits an increase in fluorescence polarization, which can be detected using specialized instruments. He has 1 patent to his name.
Career Highlights
Throughout his career, Sugden has focused on developing innovative solutions to improve disease detection methods. His work has been instrumental in advancing the field of veterinary diagnostics, particularly in identifying infections that can affect livestock and, consequently, human health.
Collaborations
Sugden has collaborated with several professionals in his field, including Michael E Jolley and Min Lin. These collaborations have contributed to the refinement and application of his patented technologies.
Conclusion
Edward A Sugden's contributions to the field of rapid detection methods exemplify the impact of innovation in biotechnology. His work continues to influence the way infectious diseases are diagnosed and managed, showcasing the importance of research and development in public health.